Pharmaceuticals

Medicine shortages in the UK and Europe have made news headlines in recent weeks. A report identified fragile supply chains as one of

In a three-part interview (view those videos here, here, and here) conducted as part of Pharmaceutical Technology® Group’s CPHI Frankfurt

In traditional drug discovery, it can take an entire decade and in excess of a billion dollars to successfully bring

With tighter regulations around biopharma manufacturing and the emergence of advanced therapies, cleanroom design is being fundamentally reshaped. This month’s

At CPHI 2025, Martin Eeles, Jan Vertommen, Anand Govindaluri, and Thomas Kern discussed how European biotechs could better leverage their

In an unexpected move, Bausch Health recently stopped participating in Medicaid and a federal government drug discount scheme known as

Company Logo The U.S. pharmaceutical CDMO market is poised for growth with opportunities driven by the rise of biologics and

CPHI Frankfurt, which will be held Oct. 28–30, 2025, is one of the pharmaceutical industry’s largest events. This year more

The Swiss big pharma company, which has outlaid $50bn to bolster drug manufacturing in the US over the next five

PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun